InvestorsHub Logo

DewDiligence

11/25/20 5:51 PM

#697 RE: DewDiligence #693

ABT director exercised_AND_HELD_$2.3M_of stock yesterday:

https://www.sec.gov/Archives/edgar/data/1800/000117911020011416/xslF345X03/edgar.xml

The options in question did not expire until 2027.

DewDiligence

01/27/21 8:40 AM

#704 RE: DewDiligence #693

ABT sold $2.4B of COVID-19 diagnostics during 4Q20!

https://abbott.mediaroom.com/2021-01-27-Abbott-Reports-Fourth-Quarter-2020-Results-Issues-Strong-Double-Digit-Growth-Forecast-for-2021

Non-GAAP EPS guidance for 2021 is >=$5.00, +37% (or more) relative to 2020’s $3.65.